US News

Indian Chemical Executive Sentenced to Prison in Landmark US Fentanyl Precursor Case

Bhavesh Lathiya, a Gujarat-based chemical company founder, has been sentenced to 54 months in a US prison for smuggling fentanyl precursor chemicals disguised as common household supplements and antacids.

Indian Chemical Executive Sentenced to Prison in Landmark US Fentanyl Precursor Case

A federal court in Brooklyn has sentenced an Indian chemical executive to 54 months in prison for his role in an international operation to smuggle and distribute precursor chemicals used in the production of fentanyl. Bhavesh Lathiya, the founder of the Surat-based firm Raxuter Chemicals, received the sentence on September 2 following his guilty plea in April to charges related to the illicit trade of substances essential for manufacturing the synthetic opioid.

The case marks a significant development in US federal law enforcement efforts, with the Department of Justice describing it as a first-of-its-kind prosecution targeting an overseas supplier for the direct role in the fentanyl supply chain. In addition to the prison term, Judge Pamela K. Chen ordered Lathiya to forfeit $24,560. Authorities have confirmed that Lathiya, who is not a US citizen, will face deportation proceedings once his sentence is served.

Deceptive Shipping and Undercover Operations

Prosecutors detailed a sophisticated scheme in which Lathiya allegedly bypassed customs and law enforcement scrutiny by mislabeling shipments. Court documents reveal that controlled precursor chemicals were frequently disguised as benign products, such as Vitamin C or antacids, and accompanied by falsified documentation to facilitate their entry into the United States and Mexico.